NO20060898L - Polypeptider til indusering av en beskyttende immunrespons mot Staphylococcus aurcus - Google Patents
Polypeptider til indusering av en beskyttende immunrespons mot Staphylococcus aurcusInfo
- Publication number
- NO20060898L NO20060898L NO20060898A NO20060898A NO20060898L NO 20060898 L NO20060898 L NO 20060898L NO 20060898 A NO20060898 A NO 20060898A NO 20060898 A NO20060898 A NO 20060898A NO 20060898 L NO20060898 L NO 20060898L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptides
- immune response
- protective immune
- induce
- seq
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Foreliggende oppfinnelse frembringer polypeptider som omfatter en aminosyresekvens som er strukturelt beslektet med Sekv. Id. nr.1, anvendelse av slike polypeptider og uttrykkingssystemer for fremstiling av slike polypeptider. Sekv. Id. nr.1 er et trunkert derivat av et fullengde -S. aureus- polypeptid. Fullengde polypeptidet blir her referert til som fullengde -"ORF0657n". Polypeptider som inneholder aminosyresekvensen ifølge Sekv. Id. nr.1 ble funnet å frembringe en beskyttende immunrespons mot S. aureus.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48984003P | 2003-07-24 | 2003-07-24 | |
US52011503P | 2003-11-14 | 2003-11-14 | |
PCT/US2004/023523 WO2005009379A2 (en) | 2003-07-24 | 2004-07-22 | Polypeptides for inducing a protective immune response against staphylococcus aureus |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060898L true NO20060898L (no) | 2006-04-24 |
Family
ID=34107815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060898A NO20060898L (no) | 2003-07-24 | 2006-02-23 | Polypeptider til indusering av en beskyttende immunrespons mot Staphylococcus aurcus |
Country Status (23)
Country | Link |
---|---|
US (2) | US20060177462A1 (no) |
EP (1) | EP1651166B8 (no) |
JP (1) | JP2007502101A (no) |
KR (1) | KR20060065643A (no) |
AT (1) | ATE457737T1 (no) |
AU (1) | AU2004258979B2 (no) |
BR (1) | BRPI0412799A (no) |
CA (1) | CA2532370A1 (no) |
CY (1) | CY1110028T1 (no) |
DE (1) | DE602004025579D1 (no) |
DK (1) | DK1651166T3 (no) |
ES (1) | ES2342778T3 (no) |
HR (1) | HRP20100240T1 (no) |
IL (1) | IL173253A0 (no) |
IS (1) | IS8213A (no) |
MX (1) | MXPA06000854A (no) |
NO (1) | NO20060898L (no) |
NZ (2) | NZ570750A (no) |
PL (1) | PL1651166T3 (no) |
PT (1) | PT1651166E (no) |
RU (1) | RU2337108C2 (no) |
SI (1) | SI1651166T1 (no) |
WO (1) | WO2005009379A2 (no) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
US20070134263A1 (en) * | 2004-02-18 | 2007-06-14 | Anderson Annaliesa S | Polypeptides for inducing a protective immune response against staphyloococcus aureus |
CA2581746A1 (en) * | 2004-10-25 | 2006-06-08 | The University Of Western Ontario | Staphylococcus aureus isd protein-based anti-infectives |
GB0526038D0 (en) * | 2005-12-21 | 2006-02-01 | Glaxosmithkline Biolog Sa | Immunogenic composition |
CN101375161A (zh) * | 2006-01-27 | 2009-02-25 | 默克公司 | 靶定金黄色葡萄球菌ORF0657n的抗原结合蛋白 |
WO2008140632A2 (en) | 2007-01-24 | 2008-11-20 | Merck & Co., Inc. | Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
ATE537839T1 (de) * | 2007-05-04 | 2012-01-15 | Martin Kroenke | Impfstoff zum schutz gegen staphylococcus aureus auf der basis zellwandassoziierter proteine |
RU2009149294A (ru) * | 2007-05-31 | 2011-07-10 | Мерк энд Ко., Инк. (US) | Антиген-связывающие белки, нацеленные на orf0657n s.aureus |
US8071561B2 (en) | 2007-08-16 | 2011-12-06 | Chrontech Pharma Ab | Immunogen platform |
JP5658564B2 (ja) | 2007-08-31 | 2015-01-28 | ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago | ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物 |
US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
US8758765B2 (en) | 2008-07-29 | 2014-06-24 | The University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
EP2376111A4 (en) | 2008-11-26 | 2013-01-09 | Merck Sharp & Dohme | POLYPEPTIDES FOR INDUCING PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS |
BRPI1010307B1 (pt) | 2009-04-03 | 2021-07-27 | University Of Chicago | Polipeptídeos variantes de proteína a (spa), composição imunogênica compreendendo os mesmos, vacina, método de produção da referida vacina, bem como uso dos referidos polipeptídeos |
NZ612315A (en) | 2009-04-14 | 2014-10-31 | Novartis Ag | Compositions for immunising against staphylococcus aureus |
GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
CA2779798C (en) | 2009-09-30 | 2019-03-19 | Novartis Ag | Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides |
CN102971009A (zh) | 2009-10-30 | 2013-03-13 | 诺华有限公司 | 金黄色葡萄球菌5型和8型荚膜多糖的纯化 |
GB0919690D0 (en) | 2009-11-10 | 2009-12-23 | Guy S And St Thomas S Nhs Foun | compositions for immunising against staphylococcus aureus |
US20130004539A1 (en) * | 2010-03-12 | 2013-01-03 | Jeffrey Weiser | Methods for preventing and treating staphylococcus aureus colonization, infection, and disease |
ES2655701T3 (es) | 2010-07-02 | 2018-02-21 | The University Of Chicago | Composiciones y métodos relacionados con variantes de la proteína A (SpA) |
US8747858B2 (en) | 2010-07-13 | 2014-06-10 | Merck Sharp & Dohme Corp. | Staphylococcus aureus surface protein SA1789 and protective vaccine based thereon |
WO2012065034A1 (en) | 2010-11-12 | 2012-05-18 | Merck Sharp & Dohme Corp. | Enolase peptide conjugate vaccines against staphylococcus aureus |
US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
CA2847204A1 (en) | 2011-09-01 | 2013-03-07 | Novartis Ag | Adjuvanted formulations of staphylococcus aureus antigens |
WO2013066731A2 (en) | 2011-10-31 | 2013-05-10 | Merck Sharp & Dohme Corp. | Protective vaccine based on staphylococcus aureus sa2451 protein |
JP6203838B2 (ja) | 2012-06-27 | 2017-09-27 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 少なくとも2つの異なる結合実体を含む、テーラーメイドの高度に選択的かつ多重特異的なターゲティング実体を選択および作製するための方法、ならびにその使用 |
WO2014001325A1 (en) | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof |
EP2872173A4 (en) | 2012-07-10 | 2016-03-23 | Merck Sharp & Dohme | STAPHYLOCOCCUS AUREUS SA2493 PROTEIN PROTECTIVE VACCINE |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
AT410798B (de) * | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
MXPA03011701A (es) * | 2001-06-15 | 2004-12-06 | Nhibitex Inc | Anticuerpos monoclonales y policlonales de reaccion que reconocen las proteinas de superficie a partir de estafilococos coagulasa-negativos y staphylococcus aureus. |
CN101979413A (zh) * | 2001-11-12 | 2011-02-23 | 诺沃挪第克公司 | 通过金属离子亲和层析法的肽纯化 |
US20080050361A1 (en) * | 2004-10-25 | 2008-02-28 | Heinrichs David E | Staphylococcus aureas specific anti-infectives |
AU2007281934B2 (en) * | 2006-01-18 | 2012-11-15 | University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
-
2004
- 2004-07-22 NZ NZ570750A patent/NZ570750A/en not_active IP Right Cessation
- 2004-07-22 AU AU2004258979A patent/AU2004258979B2/en not_active Ceased
- 2004-07-22 US US10/564,458 patent/US20060177462A1/en not_active Abandoned
- 2004-07-22 AT AT04778847T patent/ATE457737T1/de active
- 2004-07-22 PL PL04778847T patent/PL1651166T3/pl unknown
- 2004-07-22 DK DK04778847.6T patent/DK1651166T3/da active
- 2004-07-22 MX MXPA06000854A patent/MXPA06000854A/es active IP Right Grant
- 2004-07-22 ES ES04778847T patent/ES2342778T3/es not_active Expired - Lifetime
- 2004-07-22 CA CA002532370A patent/CA2532370A1/en not_active Abandoned
- 2004-07-22 EP EP04778847A patent/EP1651166B8/en not_active Expired - Lifetime
- 2004-07-22 PT PT04778847T patent/PT1651166E/pt unknown
- 2004-07-22 SI SI200431389T patent/SI1651166T1/sl unknown
- 2004-07-22 RU RU2006105498/13A patent/RU2337108C2/ru not_active IP Right Cessation
- 2004-07-22 NZ NZ544542A patent/NZ544542A/en not_active IP Right Cessation
- 2004-07-22 KR KR1020067001610A patent/KR20060065643A/ko not_active Application Discontinuation
- 2004-07-22 WO PCT/US2004/023523 patent/WO2005009379A2/en active Application Filing
- 2004-07-22 BR BRPI0412799-4A patent/BRPI0412799A/pt not_active Application Discontinuation
- 2004-07-22 DE DE602004025579T patent/DE602004025579D1/de not_active Expired - Lifetime
- 2004-07-22 JP JP2006521226A patent/JP2007502101A/ja active Pending
-
2005
- 2005-12-30 IS IS8213A patent/IS8213A/is unknown
-
2006
- 2006-01-19 IL IL173253A patent/IL173253A0/en unknown
- 2006-02-23 NO NO20060898A patent/NO20060898L/no not_active Application Discontinuation
-
2010
- 2010-04-26 HR HR20100240T patent/HRP20100240T1/hr unknown
- 2010-04-30 US US12/771,345 patent/US20100247561A1/en not_active Abandoned
- 2010-05-14 CY CY20101100419T patent/CY1110028T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005009379A3 (en) | 2006-11-30 |
HRP20100240T1 (hr) | 2010-09-30 |
BRPI0412799A (pt) | 2006-09-26 |
NZ570750A (en) | 2009-12-24 |
RU2337108C2 (ru) | 2008-10-27 |
MXPA06000854A (es) | 2006-03-30 |
US20100247561A1 (en) | 2010-09-30 |
SI1651166T1 (sl) | 2010-06-30 |
AU2004258979A1 (en) | 2005-02-03 |
PL1651166T3 (pl) | 2010-08-31 |
EP1651166B1 (en) | 2010-02-17 |
ATE457737T1 (de) | 2010-03-15 |
EP1651166B8 (en) | 2010-05-19 |
WO2005009379A2 (en) | 2005-02-03 |
EP1651166A2 (en) | 2006-05-03 |
JP2007502101A (ja) | 2007-02-08 |
CA2532370A1 (en) | 2005-02-03 |
RU2006105498A (ru) | 2006-09-10 |
IL173253A0 (en) | 2006-06-11 |
KR20060065643A (ko) | 2006-06-14 |
AU2004258979B2 (en) | 2007-12-06 |
NZ544542A (en) | 2009-01-31 |
ES2342778T3 (es) | 2010-07-14 |
EP1651166A4 (en) | 2008-03-05 |
DK1651166T3 (da) | 2010-05-31 |
IS8213A (is) | 2005-12-30 |
CY1110028T1 (el) | 2015-01-14 |
PT1651166E (pt) | 2010-04-23 |
US20060177462A1 (en) | 2006-08-10 |
DE602004025579D1 (de) | 2010-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060898L (no) | Polypeptider til indusering av en beskyttende immunrespons mot Staphylococcus aurcus | |
WO2005079315A3 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
WO2006033918A3 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
WO2005115113A3 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
WO2007001361A3 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
WO2005086663A3 (en) | Polypeptides for inducing a protective immune response against staphlococcus aureus | |
WO2006078680A3 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
BRPI0517493A (pt) | polinucleotìdeo isolado, promotor vetor de expressão, célula hospedeira e uso de um polinucleotìdeo | |
HUP0000302A2 (hu) | OB fúziós protein készítmények és módszerek | |
NO20063026L (no) | Antistoffer | |
DE60235761D1 (de) | Isoform des vegfs | |
ATE419359T1 (de) | Cdc27-homologe aus arabidopsis thaliana | |
ATE405654T1 (de) | Polypeptid mit verbesserter cytosin-deaminase- aktivität | |
ATE360701T1 (de) | Putrescin-n-methyltransferasepromotor | |
DK1344827T3 (da) | Frostbeskyttende proteiner fra basidiomycetes | |
ATE196926T1 (de) | Gen grb3-3, variante und ihre verwendungen | |
UA102522C2 (ru) | Стойкое к грибкам трансгенное растение solanaceae | |
ATE481420T1 (de) | Il-21-derivate | |
ATE414156T1 (de) | Lipase-varianten | |
PH12013502021A1 (en) | Platelet aggregation inhibitor composition | |
WO2008115415A8 (en) | Polypeptides for inducing a protective immune response against staphylococcus epidermidis | |
WO2006121664A3 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
WO2007018482A3 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
DK1005487T3 (da) | Ydre 74 kD-membranprotein fra Moraxella catarrhalis | |
ATE265221T1 (de) | Modifizierte, verkürzte regulatoren des komplementsystems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |